← Evidence map

ArticleMolecular cancer therapeutics2026

Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Hannah E Price et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41340466